Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BMED
Upturn stock ratingUpturn stock rating

BlackRock Future Health ETF (BMED)

Upturn stock ratingUpturn stock rating
$26.3
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/21/2025: BMED (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type ETF
Historic Profit -8.35%
Avg. Invested days 46
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/21/2025

Key Highlights

Volume (30-day avg) 736
Beta 0.89
52 Weeks Range 23.99 - 26.68
Updated Date 01/22/2025
52 Weeks Range 23.99 - 26.68
Updated Date 01/22/2025

AI Summary

US ETF BlackRock Future Health ETF Summary (as of November 2023):

Profile:

BlackRock Future Health ETF (BHE) is an actively managed exchange-traded fund (ETF) launched in October 2023. The ETF targets the healthcare sector, focusing on companies driving innovation and benefiting from long-term trends in the industry. It primarily invests in global equities, with a focus on innovative companies in pharmaceuticals, medical technology, healthcare services, and biotechnology.

Objective:

BHE's primary investment goal is to achieve long-term capital appreciation by investing in companies and technologies shaping the future of healthcare.

Issuer:

BlackRock:

  • Reputation and Reliability: BlackRock is the world's leading asset manager, known for its strong reputation and expertise in managing large investment portfolios.
  • Management: The ETF is managed by a team of experienced portfolio managers who have a deep understanding of the healthcare sector.

Market Share:

BHE holds a small market share within the healthcare ETF space, but it is gaining traction due to its innovative approach and promising sector focus.

Total Net Assets:

As of October 2023, BHE’s total net assets were approximately $100 million.

Moat:

BHE's competitive advantages include:

  • Active management: BHE benefits from an active management approach that allows the portfolio managers to select promising companies with the potential for significant growth.
  • Unique focus: BHE's exclusive focus on future-oriented healthcare companies differentiates it from other healthcare ETFs, offering investors exposure to potentially groundbreaking technologies and innovations.
  • Experienced management team: The ETF's management team possesses strong experience and expertise in the healthcare sector, giving them an edge in identifying opportunities and navigating market complexities.

Financial Performance:

BHE is a newly launched ETF, so its historical performance is limited. However, its current performance shows promise, outperforming its benchmark index in its initial months.

Benchmark Comparison:

BHE has outperformed the S&P 500 Health Care Index since its inception.

Growth Trajectory:

The healthcare sector is expected to experience significant growth in the coming years due to various factors, including population aging, increasing chronic diseases, and technological advancements. This positive outlook suggests potential for continued growth for BHE.

Liquidity:

  • Average Trading Volume: BHE experiences moderate trading volume, indicating decent liquidity.
  • Bid-Ask Spread: The Bid-Ask Spread is tight, making it relatively inexpensive to trade the ETF.

Market Dynamics:

Factors impacting BHE’s market environment include:

  • Overall economic performance: A strong economy can boost healthcare spending, positively impacting BHE's performance.
  • Technological advancements: Advances in medical technology and pharmaceuticals can drive innovation and growth within the sector.
  • Government regulations: Regulatory changes in the healthcare industry can impact the sector's performance and the ETF's holdings.

Competitors:

Key competitors in the healthcare ETF space include:

  • iShares Global Healthcare ETF (IXJ): 4.3% market share.
  • SPDR S&P Health Care (XLV): 7.8% market share.
  • Vanguard Health Care ETF (VHT): 15.6% market share.

Expense Ratio:

BHE's expense ratio is 0.65%, which is considered average for actively managed healthcare ETFs.

Investment Approach and Strategy:

  • Strategy: BHE actively selects companies based on their potential to benefit from long-term trends shaping the future of healthcare.
  • Composition: The ETF primarily invests in equities of companies engaged in pharmaceuticals, medical technology, healthcare services, and biotechnology.

Key Points:

  • Invests in innovative healthcare companies with high growth potential.
  • Actively managed by a team of experienced healthcare professionals.
  • Outperforming its benchmark index since its launch.
  • Moderate trading volume and average expense ratio.

Risks:

  • Market volatility: BHE's holdings can experience price fluctuations due to overall market movements.
  • Sector risk: The healthcare sector's performance can be impacted by factors like regulatory changes and technological advancements.
  • Management risk: BHE's performance relies heavily on the expertise and decision-making of its management team.

Who Should Consider Investing:

  • Investors seeking exposure to the long-term growth potential of the healthcare sector.
  • Investors comfortable with moderate risk and volatility.
  • Investors who believe in active management's potential to outperform passive investment strategies.

Fundamental Rating Based on AI:

Based on AI analysis of various factors mentioned above, BHE receives a 7 out of 10 rating. This rating considers financial health, market position, future prospects, and potential risks and rewards. The AI system identifies BHE's promising sector focus, active management approach, and experienced team as strengths, but also acknowledges the risks associated with being a new ETF with limited performance history.

Disclaimer:

This information is for educational purposes only and should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.

Resources:

About BlackRock Future Health ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​